Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19

被引：0

作者：

Jing-Chun Song

Gang Wang

Wei Zhang

Yang Zhang

Wei-Qin Li

Zhou Zhou

机构：

[1] the 908th Hospital of Joint Logistics Support Forces of Chinese PLA,Department of Critical Care Medicine

[2] the Second Affiliated Hospital of Xi’an Jiaotong University,Department of Critical Care Medicine

[3] the 900th Hospital of Joint Logistics Support Forces of Chinese PLA,Department of Emergency Medicine

[4] Fuwai Hospital,Department of Laboratory Medicine

[5] Chinese Academy of Medical Sciences,undefined

[6] Peking Union Medical College,undefined

[7] Department of Critical Care Medicine,undefined

[8] General Hospital of Eastern Theater Command of Chinese PLA,undefined

来源：

Military Medical Research | / 7卷

关键词：

COVID-19; Severe; Coagulation dysfunction; Diagnosis; Treatment;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Since December 2019, a novel type of coronavirus disease (COVID-19) in Wuhan led to an outbreak throughout China and the rest of the world. To date, there have been more than 1,260,000 COVID-19 patients, with a mortality rate of approximately 5.44%. Studies have shown that coagulation dysfunction is a major cause of death in patients with severe COVID-19. Therefore, the People’s Liberation Army Professional Committee of Critical Care Medicine and Chinese Society on Thrombosis and Hemostasis grouped experts from the frontline of the Wuhan epidemic to come together and develop an expert consensus on diagnosis and treatment of coagulation dysfunction associated with a severe COVID-19 infection. This consensus includes an overview of COVID-19-related coagulation dysfunction, tests for coagulation, anticoagulation therapy, replacement therapy, supportive therapy and prevention. The consensus produced 18 recommendations which are being used to guide clinical work.

引用